Bladder Cancer - Results from #80

Bacillus Calmette-Guérin Salvage Therapy: Definitions and Context. December 25, 2019

Ureteroenteric strictures: a single center experience comparing Bricker versus Wallace ureteroileal anastomosis in patients after urinary diversion for bladder cancer. December 24, 2019

Propofol exhibits a tumor-suppressive effect and regulates cell viability, migration and invasion in bladder carcinoma by targeting the microRNA-10b/HOXD10 signaling pathway. December 24, 2019

Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors. December 24, 2019

Bladder Cancer: Depression, Anxiety, and Suicidality Among the Highest-risk Oncology Patients. December 23, 2019

Small cell carcinoma of the bladder: the characteristics of molecular alterations, treatment, and follow-up. December 23, 2019

Efficacy of Palliative Bladder Radiotherapy for Hematuria in Advanced Bladder Cancer Using Contemporary Radiotherapy Techniques. December 23, 2019

Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with checkpoint inhibitors. December 20, 2019

Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence. December 20, 2019

ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer. December 20, 2019

Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC. December 19, 2019

Toll-like receptors: The role in bladder cancer development, progression and immunotherapy. December 19, 2019

Decision Regret Related to Urinary Diversion Choice among Patients Treated with Cystectomy. December 19, 2019

Extended Lymph Node Dissection for Bladder Cancer: Do Clinical Trials Rule Out a Benefit? December 19, 2019

FDA Approves Enfortumab Vedotin to Treat Advanced Urothelial Carcinoma December 18, 2019

FDA ODAC Recommends Pembrolizumab for the Treatment of Certain Patients with High-Risk, Non-Muscle Invasive Bladder Cancer December 18, 2019

Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial. December 18, 2019

Proteomic Analysis of Bladder Cancer Cells Reveals Potential Candidates of Biomarkers in Bladder Tumorigenesis. December 18, 2019

Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder. December 18, 2019

Food consumption, meat cooking methods and diet diversity and the risk of bladder cancer. December 17, 2019

Page 5 of 325